Results 171 to 180 of about 5,048,722 (239)
Impact of regular physiotherapy intervention on the function and quality of life of pediatric patients diagnosed with Mucopolysaccharidosis. [PDF]
Dealy J, Inbar-Feigenberg M.
europepmc +1 more source
Guidance for Home Enzyme Replacement Therapy in Children and Adolescents Diagnosed with Mucopolysaccharidoses: A Scoping Review Protocol. [PDF]
Oliveira VR +5 more
europepmc +1 more source
[Case of mucopolysaccharidosis II--Hunter's syndrome].
M, Walczak +3 more
openaire +1 more source
Acute Airway Crisis in Mucopolysaccharidosis VI: Management Challenges. [PDF]
Tulebayeva A, Gadepalli C, Sharipova M.
europepmc +1 more source
Adult disease burden in patients with mucopolysaccharidosis type I H (Hurler syndrome): A comprehensive literature review with patient case analysis. [PDF]
Lusk EN +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Therapeutic Options for Mucopolysaccharidosis II (Hunter Disease)
Current Pharmaceutical Design, 2020Background:Mucopolysaccharidosis type II (Hunter syndrome, or MPS II) is an X-linked lysosomal disorder caused by the deficiency of iduronate-2-sulfatase, which leads to the accumulation of glycosaminoglycans (GAGs) in a variety of tissues, resulting in a multisystemic disease that can also impair the central nervous system (CNS).Objective:This review ...
Francyne Kubaski +5 more
openaire +3 more sources
Nasal Polyposis in mucopolysaccharidosis type II
BMJ Case Reports, 2021Mucopolysaccharidosis (MPS) type II is a rare multisystem disorder resulting from the accumulation of breakdown products of glycosaminoglycans in the body tissues. Many patients with this disease undergo ENT (ear, nose and throat) surgeries such as adenotonsillectomy and tympanocentesis at a very early age, much before the diagnosis of MPS.
Sushmitha Kabekkodu +3 more
openaire +2 more sources

